Off-Label Use of Drugs and Adverse Drug Reactions in Pediatric Units: A Prospective, Multicenter Study

Publisher： Bentham Science Publishers

E-ISSN： 2212-3911|13|3|200-207

ISSN： 1574-8863

Source： Current Drug Safety, Vol.13, Iss.3, 2018-11, pp. : 200-207

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Unlicensed and off‐label drug use: a prospective study in French NICU

By  

ACTA PAEDIATRICA, Vol. 104, Iss. 5, 2015-05 ,pp. : e228-e231

John Wiley & Sons Inc

Access to resources Recommend Favorite

FDA issues warning about off‐label pediatric use of tramadol

By  

THE BROWN UNIVERSITY CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY UPDATE, Vol. 17, Iss. 11, 2015-11 ,pp. : 8-8

John Wiley & Sons Inc

Access to resources Recommend Favorite

Off‐label use of nicardipine as tocolytic and acute pulmonary oedema: a post‐marketing analysis of adverse drug reaction reports in EudraVigilance

By  

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 24, Iss. 11, 2015-11 ,pp. : 1220-1224

John Wiley & Sons Inc

Access to resources Recommend Favorite

Off-label drug use ‐ price analysis for Avastin ® in ophthalmology

By Michels Stephan   Kurz-Levin Malaika   Schmitz Christian  

International Journal of Pharmaceutical and Healthcare Marketing, Vol. 3, Iss. 1, 2009-04 ,pp. : 59-73

Emerald Group Publishing Ltd

Access to resources Recommend Favorite

Off‐label paediatric drug use in an Indonesian community setting

By  

JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol. 40, Iss. 4, 2015-08 ,pp. : 409-412

John Wiley & Sons Inc

Access to resources Recommend Favorite